Ovarian Cancer

OV-10: Cisplatin + Paclitaxel vs Cisplatin + Cyclophosphamide in Advanced Ovarian Cancer

JAVELIN Ovarian 200: Avelumab Alone or With Pegylated Liposomal Doxorubicin in Platinum-Resistant or Platinum-Refractory Ovarian Cancer

JAVELIN Ovarian 100: Avelumab With or After Frontline Chemotherapy in Previously Untreated Advanced Epithelial Ovarian Cancer

GOG 114: IP Cisplatin Plus IV Paclitaxel vs Standard IV Cisplatin/Paclitaxel in Stage III Ovarian Cancer

AGO-OVAR 2.5: Gemcitabine Plus Carboplatin versus Carboplatin in Platinum-Sensitive Recurrent Ovarian Cancer

SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis)

AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer

ICON4/AGO-OVAR-2.2: Paclitaxel–Platinum vs Platinum in Platinum-Sensitive Relapsed Ovarian Cancer

SORAYA: Mirvetuximab Soravtansine in FRα-High Platinum-Resistant Ovarian Cancer

GOG 182/ICON5: Five-Arm First-Line Trial in Advanced Ovarian Cancer